
New Drug Enhances PAOD Therapy with Patient’s Immune Cells

Peripheral artery occlusive disease (PAOD) ranks among the most frequent chronic diseases worldwide. Common therapies comprise mechanical interventions, which are not suitable for a considerable number of patients. We offer a new pharmaceutical, achieving an almost healthy blood flow due to an increased growth of collateral vessels. For that immune cells of the patient are used, giving reason to expect a good tolerance and thereby avoiding rejection reactions and the transmission of pathogens.
Further information: PDF
ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20
Contact
Peter Lösler
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.